ArticlePloS one2026
A novel hybrid framework integrating GA-driven 3D ResUNetGAN for MRI brain tumor segmentation.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate brain tumor segmentation by multi-modal MRI is crucial for diagnosis, treatment planning, and prognostic assessment. This work proposes a novel hybrid architecture within a GA optimized by 3D residual U-Net (ResUNet) with generative adversarial network (GAN) for the accurate segmentation of tumor subregions, namely the tumor core (TC), whole tumor (WT), and enhancing tumor (ET), using a dataset collected from BraTS2023 (437 training and 188 validation). By using GAs, we enable the computer to automatically find the best model structure and training settings, which helps keep the model simple enough to avoid overfitting while being powerful enough to generalise well to new data. The GAN part of our method trains the model to draw more realistic and consistent boundaries around tumor regions in MRI scans, thereby improving the overall quality of the segmentation. In our experiments, this GA-ResUNetGAN approach performed better than several leading methods, such as 3D UNet, DynUNet, UNETR, SwinUNETR, and the standard ResUNet, especially in accurately identifying TC, WT, and ET parts-achieving Dice scores of 0.94, 0.96, and 0.91 on the validation set. In addition, K-Fold cross-validation was performed to ensure consistent performance across different data splits. While the method involves more processing work than some baseline techniques, it provides improved segmentation quality and boundary delineation on the evaluated dataset. These results demonstrate the advantages of combining evolutionary optimization with adversarial deep learning for challenging medical imaging tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.